Three new loci for determining X chromosome inactivation patterns

Journal of Molecular Diagnostics

Volumn 13, Issue 5, 2011, Pages 537-540

  Bertelsen, Birgitte ^a   Tümer, Zeynep ^a   Ravn, Kirstine ^a  

^a JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RESTRICTION ENDONUCLEASE;

AR GENE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LOCUS; HETEROZYGOSITY; HUMAN; MOLECULAR DIAGNOSIS; PCSK 1N GENE; POLYMERASE CHAIN REACTION; RELIABILITY; SLITRK 4 GENE; X CHROMOSOME INACTIVATION; ZDHHC 15 GENE;

EID: 82755162703     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2011.05.003     Document Type: Article

References (15)

1. Lyon MF: X-chromosome inactivation as a system of gene dosage compensation to regulate gene expression. Prog Nucleic Acid Res Mol Biol 1989, 36:119-130
2. Orstavik KH: X chromosome inactivation in clinical practice. Hum Genet 2009, 126:363-373
3. Nelson DL: NEMO, NFkappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev 2006, 16:282-288
4. Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RP, Wevers RA, Salvayre R, Levade T: Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. J Med Genet 1996, 33:682-688 (Pubitemid 26270929)
5. Tefferi A, Thibodeau SN, Solberg LA Jr: Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990, 75:1770-1773 (Pubitemid 20161488)
6. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF: Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A 1991, 88:6848-6852 (Pubitemid 21915047)
7. Lee ST, McGlennen RC, Litz CE: Clonal determination by the fragile X (FMR1) and phosphoglycerate kinase (PGK) genes in hematological malignancies. Cancer Res 1994, 54:5212-5216 (Pubitemid 24313502)
8. Hendriks RW, Chen ZY, Hinds H, Schuurman RK, Craig IW: An X chromosome inactivation assay based on differential methylation of a CpG island coupled to a VNTR polymorphism at the 5′ end of the monoamine oxidase A gene. Hum Mol Genet 1992, 1:187-194
9. Beever C, Lai BP, Baldry SE, Peñaherrera MS, Jiang R, Robinson WP, Brown CJ: Methylation of ZNF261 as an assay for determining X chromosome inactivation patterns. Am J Med Genet A 2003, 120A:439-441 (Pubitemid 37063786)
10. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992, 51:1229-1239 (Pubitemid 23001082)
11. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R: Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992, 12:241-253
12. Sleddens HF, Oostra BA, Brinkmann AO, Trapman J: Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 1992, 20:1427
13. Salstrom JL: X-inactivation and the dynamic maintenance of gene silencing. Mol Genet Metab 2007, 92:56-62
14. Lau AW, Brown CJ, Peñaherrera M, Langlois S, Kalousek DK, Robinson WP: Skewed X-chromosome inactivation is common in fetuses or newborns associated with confined placental mosaicism. Am J Hum Genet 1997, 61:1353-1361 (Pubitemid 28046912)
15. Busque L, Mio R, Mattiolo J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG: Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996, 88:59-65 (Pubitemid 26230671)